Vigabatrin in infantile spasms: Preliminary result

Journal of the Medical Association of Thailand

Volumn 82, Issue 10, 1999, Pages 1000-1005

  Visudtibhan, Anannit ^a   Chiemchanya, Surang ^a   Visudhiphan, Pongsakdi ^a   Phusirimongkol, Siriporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Children; Efficacy; Infantile Spasms; Side effects; Vigabatrin

Indexed keywords

CORTICOTROPIN; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT;

ALERTNESS; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG SAFETY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INFANT; INFANTILE SPASM; MALE; OROFACIAL DYSKINESIA; PRESCHOOL CHILD; SEIZURE; THAILAND; CLINICAL TRIAL; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FOLLOW UP; REMISSION; TABLET; TIME;

ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; REMISSION INDUCTION; SPASMS, INFANTILE; TABLETS; TIME FACTORS; VIGABATRIN;

EID: 0032589675     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jeavons PM, Bower BD, Dimitrakoudi M. Long term prognosis of 150 cases of "West syndrome". Epilepsia 1973; 14: 153-64.
2. Lacy JR, Penry PK. Infantile spasms. New York: Raven Press, 1976.
3. Hrachovy RA, Frost JD Jr. Infantile spasms. Pediatr Clin North Am 1989; 36: 311-29.
4. Didenvall R. Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995; 36: 572-4.
5. Duchowny M, Harvey AS. Pediatric epilepsy syndromes: an update and critical review. Epilepsia 1996; 37(suppl 1): S26-S40.
6. Glaze DJ, Hrachowy RA, Frost JD, et al. Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisolone. J Pediatr 1988; 112: 389-96.
7. Hellstrom B, Oberger E. ACTH and corticosteroid treatment of infantile spasms with hyperrhythmia. Acta Pediatr Scand 1965; 54: 180-7.
8. Riikonen R, Donner M. ACTH therapy in infantile spasms: Side effects. Arch Dis Child 1980; 55: 664-72.
9. Appleton RE. Vigabatrin in the management of generalized seizures in children. Seizure 1995; 4: 45-8.
10. Chiron C, Dumas C, Dulac O, et al. Vigabatrin versus hydrocortisone as first line monotherapy in infantile spasms. Epilepsia 1995; 36 (suppl 3): S265.
11. Kellaway P, Frost JD, Hrachovy RA. Infantile spasms. In: Antiepileptic Drug Therapy. Morselli PL, Pippenger CE, Pencry JK eds. New York: Raven Press, 1983: 115-36.
12. Siemes H, Spohr HL, Michael TH. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988; 29: 553-60.
13. Prats JM, Garaizar C, Rua MJ, et al. Infantile spasms treated with high doses of sodium valproate: Initial response and follow-up. Dev Med Child Neurol 1991; 33: 617-5.
14. Livingston JH, Beaumont D, Arzimanogi A, Aicardi J. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmac 1989; 27: 109S-112S.
15. Luna D, Dulac O, Pajot N, Beaumont D. Vigabatrin in the treatment of childhood epilepsy, a single placebo-controlled study. Epilepsia 1989; 30: 430-7.
16. Dulac O, Chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991; 6(suppl 2): S30-S37.
17. Vles JSH, van der Heyden AMHG, Ghiji A, Troost J. Vigabatrin in the treatment of infantile spasms. Neuropediatrics 1993; 24: 230-1.
18. Fois A, Buoni S, Di Bartolo RM, Di Marco V, Mostardini R. Vigabatrin treatment in children. Child's Nerv Syst 1994; 10: 244-8.
19. Urdrall P, Alving J, Gram L, Hogenhaven H. Vigabatrin in childhood epilepsy: A 5-year follow-up study. Neuropediatrics 1995; 26: 253-6.
20. Vigevano F. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997; 38: 1270-4.
21. Aicardi J, Sabril IS. Investigator and Peer Review Groups, Mumford JP, Dumas C and Wood S. Vigabatrin as Initial Therapy for Infantile Spasms : A European Retrospective Survey. Epilepsia 1996; 37: 638-42.
22. Fisher RS. Emerging antiepileptic drugs. Neurol 1993; 43(suppl 5): S12-S20.
23. Schmitt B, Wohlrab G, Boltshauser E. Vigabatrin in newly diagnosed infantile spasms. Neuropediatrics 1994; 25:54.
24. Buti D, Rota M, Lini M, Bardini MR, Guarnieri M, Marvulli I. First line monotherapy with vigabatrin in infantile spasms: long term clinical and EEG evolution in 12 patients. Epilepsia 1995; 36 (suppl 3): S102.
25. Fisher RS, Kalviainen R, Tanganelli P, Regesta G. Newer antiepileptic drugs as monotherapy: Data on vigabatrin. Neurology 1996; 47 (suppl 1): S2-S5.
26. Chiron C, Dulac O, Luna D, et al. Vigabatrin in infantile spasms. Lancet 1990; 335: 363-4.
27. Driefuss F, Farwell J, Holmes G, et al. Infantile spasms. Comparative trial of nitrazepam and corticotropin. Arch Neurol 1986; 43: 1107-10.
28. Farrel K. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 1986; 27 (suppl 1): S45-S52.
29. Chamberlain MC. Nitrazepam for refractory infantile spasms and the Lennox-Gastaut syndrome. J Child Neurol 1996; 11: 31-4.
30. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndrome. Neurology 1993; 43(suppl 5): S21-S23.
31. Mumford JP, Cannon DJ. Vigabatrin. Epilepsia 1994; 35 (suppl 5): S25-28.
32. Sander JWAS, Hart YM, Trimble MR, Shorvon SD. Vigabatrin and behavioural disturbance. Lancet 1990; 335:57.
33. Naumann M, Supprian T, Komhuber J, Lange KW, Reiners K. Bipolar affective psychosis after vigabatrin. Lancet 1994; 343: 606-7.
34. Aldenkamp AP, Vermeulen J, Mulder OG, et al. Gamma-vinyl GABA (vigabatrin) and mood disturbances. Epilepsia 1994; 35: 999-1004.
35. Dodrill CB, Arnett JL, Sommerville KW, et al. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Neurology 1993; 43: 2501-7.
36. Monaco F. Cognitive effects of vigabatrin; a review. Neurol 1996; 47 (suppl 1): S6-S11.
37. Monaco F, Torta R, Cicolin A, et al. Lack of association between vigabatrin and impaired cognition. J Inter Med Res 1997; 25: 296-301.
38. Crofts K, Brennan R, Kearney P, O'Connor G. Vigabatrin-induced optic neuropathy. J Neurol 1997; 244: 666-7.
39. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997; 314: 180-1.
40. Wong IC, Mawer GE, Sander JWAS. Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent. BMJ 1997; 314(7095): 1693-4.
41. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998; 50: 614-8.
42. Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ 1998; 316: 233.
43. Rao GP, Ah Fat F, Kyle G, Leach JP, Chadwick DW, Batterbury M. Study is needed of visual field defects associated with any long term antiepileptic drug. BMJ 1998; 317: 206.
44. Ruether K, Pung T, Kellner U, Schmitz B, Hartmann C. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol 1998; 116: 817-9.